The lost science of formulation

Marc Brown

doi:10.1016/S1359-6446(05)03643-3

The lost science of formulation

Marc Brown

Research output: Contribution to journal › Editorial › peer-review

7 Citations (Scopus)

Abstract

The current R&D outsourcing market is growing annually at ∼15%, with a predicted market of US$36 billion by 2010. However, top tier contract research organizations (CROs) are attempting to transform their profitability by focusing on higher value-added services, such as preclinical and bioanalytical testing, leading to a shortage of high-quality formulation CROs

Original language	English
Pages (from-to)	1405-1407
Number of pages	3
Journal	Drug Discovery Today
Volume	10
Issue number	21
DOIs	https://doi.org/10.1016/S1359-6446(05)03643-3
Publication status	Published - 1 Nov 2005

Access to Document

10.1016/S1359-6446(05)03643-3

Cite this

@article{8bd1c22a70a142009f419303900055d7,

title = "The lost science of formulation",

abstract = "The current R&D outsourcing market is growing annually at ∼15%, with a predicted market of US$36 billion by 2010. However, top tier contract research organizations (CROs) are attempting to transform their profitability by focusing on higher value-added services, such as preclinical and bioanalytical testing, leading to a shortage of high-quality formulation CROs",

author = "Marc Brown",

year = "2005",

month = nov,

day = "1",

doi = "10.1016/S1359-6446(05)03643-3",

language = "English",

volume = "10",

pages = "1405--1407",

journal = "Drug Discovery Today",

issn = "1359-6446",

publisher = "Elsevier",

number = "21",

}

TY - JOUR

T1 - The lost science of formulation

AU - Brown, Marc

PY - 2005/11/1

Y1 - 2005/11/1

N2 - The current R&D outsourcing market is growing annually at ∼15%, with a predicted market of US$36 billion by 2010. However, top tier contract research organizations (CROs) are attempting to transform their profitability by focusing on higher value-added services, such as preclinical and bioanalytical testing, leading to a shortage of high-quality formulation CROs

AB - The current R&D outsourcing market is growing annually at ∼15%, with a predicted market of US$36 billion by 2010. However, top tier contract research organizations (CROs) are attempting to transform their profitability by focusing on higher value-added services, such as preclinical and bioanalytical testing, leading to a shortage of high-quality formulation CROs

U2 - 10.1016/S1359-6446(05)03643-3

DO - 10.1016/S1359-6446(05)03643-3

M3 - Editorial

SN - 1359-6446

VL - 10

SP - 1405

EP - 1407

JO - Drug Discovery Today

JF - Drug Discovery Today

IS - 21

ER -

The lost science of formulation

Abstract

Access to Document

Fingerprint

Cite this